rf-fullcolor.png

 

November 7, 2019
by Zachary Brennan

EC Extends Deadline for Experts to Apply for MDR/IVDR Panels

The European Commission (EC) said Thursday that it has extended the deadline by almost two weeks for experts to apply to be a part of panels that will evaluate high-risk medical devices and in vitro diagnostics (IVDs) under the incoming Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). The new deadline is 24 November.

As first discussed in September, panel experts are expected to be objective (EC says they must have no financial or other interests in the device or notified body industries), appointed for three-year terms and paid €450 per each full working day. The experts will be paid for their preparatory work and participation (in person or electronically) in the expert panel meetings and in other related activities.

“The selection criteria included in the call for expression of interest should ensure that highly qualified advisors with a sufficient level of up-to-date clinical, scientific or technical expertise in the relevant identified areas are selected, and that advisors are able to act independently and in the public interest,” the EC said.

Panels will cover each of the following 11 areas:
  1. Orthopedics, traumatology, rehabilitation and rheumatology
  2. Circulatory system
  3. Neurology
  4. Respiratory system, anesthesiology and intensive care
  5. Endocrinology and diabetes
  6. General and plastic surgery and dentistry
  7. Obstetrics and gynecology, including reproductive medicine
  8. Gastroenterology and hepatology
  9. Nephrology and urology
  10. Ophthalmology
  11. In vitro diagnostics
Call for expression of interest for expert panels
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.